Skip to content

    Recently Viewed

      Listening...

      Johnson & Johnson to Participate in the 2022 Wells Fargo Securities Healthcare Conference

      Share Article
      share to

      New Brunswick, NJ (August 2nd, 2022) -- Johnson & Johnson (NYSE: JNJ) will participate in the 2022 Wells Fargo Securities Healthcare Conference at the Encore Boston Harbor in Everett, MA on Wednesday, September 7th. Ashley McEvoy, Executive Vice President, Worldwide Chairman, MedTech will represent the Company in a session scheduled at 11:00 a.m. (Eastern Time).

      This conference call will be available to investors and other interested parties by visiting the Johnson & Johnson website at www.investor.jnj.com.

      A webcast and podcast replay will be available approximately 48 hours after the live webcast.

      ###

      Press Contacts:
      Rachel Hooper
      rhooper@its.jnj.com

      Investor Contacts:
      Sarah Wood
      (732) 524-2617

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.